For instance, analysis of 2-HG by proton MRS is shown to correlate with either IDH1 or IDH2 mutations in the tumor [61], suggesting that elevated 2-HG levels in IDH-mutated gliomas may one day offer crucial diagnostic and prognostic data. The gene discussed is IDH1; the disease is central nervous system cancer.